Breast cancer patients with lymph node metastasis, distant metastasis or late TNM stage luminal-like subtype (stage III&IV), have higher levels of SLC7A11 and vimentin (Fig. 1F, G). Here, VIM is linked to metastatic malignant neoplasm in the lymph nodes.